Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Go back to Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026| (NASDAQ: DFTX) | Delayed: 36.67 +12.19 (49.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.48 | 52 Week High | $ | |||
| Open | $38.58 | 52 Week Low | $ | |||
| Day High | $39.16 | P/E | N/A | |||
| Day Low | $35.13 | EPS | $ | |||
| Volume | 20,121,762 | |||||

